Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2.

Furuhashi M, Tuncman G, Görgün CZ, Makowski L, Atsumi G, Vaillancourt E, Kono K, Babaev VR, Fazio S, Linton MF, Sulsky R, Robl JA, Parker RA, Hotamisligil GS
Nature. 2007 447 (7147): 959-65

PMID: 17554340 · PMCID: PMC4076119 · DOI:10.1038/nature05844

MeSH Terms (20)

Adipocytes Adipose Tissue Animals Apolipoproteins E Atherosclerosis Biphenyl Compounds Cell Line Cholesterol Diabetes Mellitus Fatty Acid-Binding Proteins Humans Inflammation Liver Macrophages Mice Mice, Inbred C57BL Mice, Mutant Strains Models, Biological Obesity Pyrazoles

Connections (1)

This publication is referenced by other Labnodes entities: